• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow.ADAMTS13羧基末端血小板反应蛋白1重复序列与CUB结构域之间的协同活性对于在血流状态下识别血管性血友病因子至关重要。
Blood. 2007 Sep 15;110(6):1887-94. doi: 10.1182/blood-2007-04-083329. Epub 2007 May 31.
2
Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.ADAMTS13 的羧基末端以依赖游离巯基的方式直接抑制血小板聚集和在流动条件下超大 vWF 多聚体的形成。
Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):397-407. doi: 10.1161/ATVBAHA.113.302547. Epub 2013 Dec 19.
3
The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor.ADAMTS13的近端羧基末端结构域决定底物特异性,并且都是切割血管性血友病因子所必需的。
J Biol Chem. 2005 Aug 19;280(33):29428-34. doi: 10.1074/jbc.M505513200. Epub 2005 Jun 23.
4
Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.体外研究表明,血栓调节蛋白-1 和 ADAMTS13 可与 vWF A2 和 A3 结构域竞争结合。
Thromb Res. 2010 Oct;126(4):e260-5. doi: 10.1016/j.thromres.2010.07.009. Epub 2010 Aug 11.
5
The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo.鼠 ADAMTS13 的远羧基末端结构域影响体内血小板修饰的 vWF 串的蛋白水解。
J Thromb Haemost. 2010 Oct;8(10):2305-12. doi: 10.1111/j.1538-7836.2010.04008.x.
6
Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13.血管性血友病因子的裂解需要金属蛋白酶ADAMTS13的间隔域。
J Biol Chem. 2003 Aug 8;278(32):30136-41. doi: 10.1074/jbc.M305331200. Epub 2003 Jun 5.
7
A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.一个新的ADAMTS13结合位点,其在球形VWF表面组成性暴露。
Blood. 2009 Sep 24;114(13):2819-28. doi: 10.1182/blood-2009-05-224915. Epub 2009 Jul 8.
8
Binding of ADAMTS13 to von Willebrand factor.ADAMTS13与血管性血友病因子的结合。
J Biol Chem. 2005 Jun 10;280(23):21773-8. doi: 10.1074/jbc.M502529200. Epub 2005 Apr 11.
9
Conformational activation of ADAMTS13.ADAMTS13的构象激活
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18578-83. doi: 10.1073/pnas.1411979112. Epub 2014 Dec 15.
10
Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.通过突变和小角度 X 射线散射探索功能性 ADAMTS13 的“最小”结构。
Blood. 2019 Apr 25;133(17):1909-1918. doi: 10.1182/blood-2018-11-886309. Epub 2019 Jan 28.

引用本文的文献

1
Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation.开发一种抗蛋白酶的ADAMTS13以提高其对蛋白水解降解的稳定性。
Blood Adv. 2025 Jun 10;9(11):2695-2705. doi: 10.1182/bloodadvances.2024015212.
2
Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity.PRMT1介导的精氨酸甲基化影响ADAMTS13的分泌及酶活性。
Arterioscler Thromb Vasc Biol. 2025 Apr;45(4):506-522. doi: 10.1161/ATVBAHA.124.322249. Epub 2025 Feb 13.
3
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura.新兴遗传性血栓性血小板减少性紫癜治疗方法的作用新机制。
Expert Rev Hematol. 2024 Jul;17(7):341-351. doi: 10.1080/17474086.2024.2356763. Epub 2024 May 20.
4
Targeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura.靶向免疫介导性血栓性血小板减少性紫癜患者血流中中性粒细胞胞外诱捕网的积聚。
Blood Adv. 2024 May 28;8(10):2536-2551. doi: 10.1182/bloodadvances.2023011617.
5
Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.凝血因子 VIII 在体内调节血管性血友病因子的稳态。
J Thromb Haemost. 2023 Dec;21(12):3477-3489. doi: 10.1016/j.jtha.2023.09.004. Epub 2023 Sep 17.
6
A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometry.氢氘交换质谱法揭示的ADAMTS-13变构调节潜在新机制
Res Pract Thromb Haemost. 2022 Dec 13;7(1):100012. doi: 10.1016/j.rpth.2022.100012. eCollection 2023 Jan.
7
Mechanisms of ADAMTS13 regulation.ADAMTS13 的调控机制。
J Thromb Haemost. 2022 Dec;20(12):2722-2732. doi: 10.1111/jth.15873. Epub 2022 Sep 22.
8
A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura.一种针对 ADAMTS-13 远端羧基末端的人源单克隆抗体调节其对血栓性血小板减少性紫癜抑制剂的敏感性。
J Thromb Haemost. 2021 Aug;19(8):1888-1895. doi: 10.1111/jth.15332. Epub 2021 May 11.
9
Factor VIII binding affects the mechanical unraveling of the A2 domain of von Willebrand factor.VIII 因子结合影响 von Willebrand 因子 A2 结构域的机械展开。
J Thromb Haemost. 2020 Sep;18(9):2169-2176. doi: 10.1111/jth.14962. Epub 2020 Jul 23.
10
Novel mutations in ADAMTS13 CUB domains cause abnormal pre-mRNA splicing and defective secretion of ADAMTS13.ADAMTS13 CUB 结构域的新突变导致异常的前体 mRNA 剪接和 ADAMTS13 分泌缺陷。
J Cell Mol Med. 2020 Apr;24(7):4356-4361. doi: 10.1111/jcmm.15025. Epub 2020 Feb 19.

本文引用的文献

1
Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease.外位点相互作用有助于抗血栓性ADAMTS13金属蛋白酶对血管性血友病因子的张力诱导切割。
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19099-104. doi: 10.1073/pnas.0607264104. Epub 2006 Dec 4.
2
Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.血管性血友病因子A2结构域中ADAMTS-13核心结合位点的鉴定
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18470-4. doi: 10.1073/pnas.0609190103. Epub 2006 Nov 22.
3
Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.血栓性血小板减少性紫癜患者体内针对ADAMTS - 13的抑制性自身抗体可结合ADAMTS - 13蛋白酶,并可能在体内加速其清除。
J Thromb Haemost. 2006 Aug;4(8):1707-17. doi: 10.1111/j.1538-7836.2006.02025.x.
4
Human endothelial cells synthesize and release ADAMTS-13.人内皮细胞合成并释放ADAMTS - 13。
J Thromb Haemost. 2006 Jun;4(6):1396-404. doi: 10.1111/j.1538-7836.2006.01959.x.
5
Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo.大鼠肝星状细胞在体内外激活后ADAMTS - 13蛋白水解活性增强。
J Thromb Haemost. 2006 May;4(5):1063-70. doi: 10.1111/j.1538-7836.2006.01893.x.
6
Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts.血管内皮细胞和犬肾细胞中ADAMTS13的顶端分选取决于CUB结构域及其与脂筏的关联。
Blood. 2006 Oct 1;108(7):2207-15. doi: 10.1182/blood-2006-02-002139. Epub 2006 Apr 4.
7
Systemic antithrombotic effects of ADAMTS13.ADAMTS13的全身抗血栓形成作用。
J Exp Med. 2006 Mar 20;203(3):767-76. doi: 10.1084/jem.20051732. Epub 2006 Mar 13.
8
Zinc and calcium ions cooperatively modulate ADAMTS13 activity.锌离子和钙离子协同调节ADAMTS13活性。
J Biol Chem. 2006 Jan 13;281(2):850-7. doi: 10.1074/jbc.M504540200. Epub 2005 Nov 11.
9
Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.脓毒症诱发的弥散性血管内凝血患者中血管性血友病因子裂解蛋白酶(ADAMTS13)的严重继发性缺乏:其与肾衰竭发生的相关性
Blood. 2006 Jan 15;107(2):528-34. doi: 10.1182/blood-2005-03-1087. Epub 2005 Sep 27.
10
Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.血小板衍生的血管性血友病因子裂解金属蛋白酶ADAMTS-13
J Thromb Haemost. 2005 Nov;3(11):2536-44. doi: 10.1111/j.1538-7836.2005.01561.x. Epub 2005 Sep 13.

ADAMTS13羧基末端血小板反应蛋白1重复序列与CUB结构域之间的协同活性对于在血流状态下识别血管性血友病因子至关重要。

The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow.

作者信息

Zhang Ping, Pan Weilan, Rux Ann H, Sachais Bruce S, Zheng X Long

机构信息

Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

出版信息

Blood. 2007 Sep 15;110(6):1887-94. doi: 10.1182/blood-2007-04-083329. Epub 2007 May 31.

DOI:10.1182/blood-2007-04-083329
PMID:17540842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1976376/
Abstract

ADAMTS13 cleaves von Willebrand factor (VWF) between Tyr(1605) and Met(1606) residues at the central A2 subunit. The amino-terminus of ADAMTS13 protease appears to be sufficient to bind and cleave VWF under static and denatured condition. However, the role of the carboxyl-terminus of ADAMTS13 in substrate recognition remains controversial. Present study demonstrates that ADAMTS13 cleaves VWF in a rotation speed- and protease concentration-dependent manner on a mini vortexer. Removal of the CUB domains (delCUB) or truncation after the spacer domain (MDTCS) significantly impairs its ability to cleave VWF under the same condition. ADAMTS13 and delCUB (but not MDTCS) bind VWF under flow with dissociation constants (K(D)) of about 50 nM and about 274 nM, respectively. The isolated CUB domains are neither sufficient to bind VWF detectably nor capable of inhibiting proteolytic cleavage of VWF by ADAMTS13 under flow. Addition of the TSP1 5-8 (T5-8CUB) or TSP1 2-8 repeats (T2-8CUB) to the CUB domains restores the binding affinity toward VWF and the inhibitory effect on cleavage of VWF by ADAMTS13 under flow. These data demonstrate directly and quantitatively that the cooperative activity between the middle carboxyl-terminal TSP1 repeats and the distal carboxyl-terminal CUB domains may be crucial for recognition and cleavage of VWF under flow.

摘要

ADAMTS13在中央A2亚基的Tyr(1605)和Met(1606)残基之间切割血管性血友病因子(VWF)。在静态和变性条件下,ADAMTS13蛋白酶的氨基末端似乎足以结合并切割VWF。然而,ADAMTS13羧基末端在底物识别中的作用仍存在争议。目前的研究表明,在微型涡旋仪上,ADAMTS13以转速和蛋白酶浓度依赖性方式切割VWF。去除CUB结构域(delCUB)或在间隔结构域(MDTCS)后截断显著损害其在相同条件下切割VWF的能力。ADAMTS13和delCUB(但不是MDTCS)在流动状态下结合VWF,解离常数(K(D))分别约为50 nM和约274 nM。分离的CUB结构域既不足以检测到与VWF的结合,也不能在流动状态下抑制ADAMTS13对VWF的蛋白水解切割。向CUB结构域添加TSP1 5-8(T5-8CUB)或TSP1 2-8重复序列(T2-8CUB)可恢复对VWF的结合亲和力以及在流动状态下对ADAMTS13切割VWF的抑制作用。这些数据直接且定量地证明,中间羧基末端TSP1重复序列和远端羧基末端CUB结构域之间的协同活性对于在流动状态下识别和切割VWF可能至关重要。